Kush Bhatt

Should we skip the trip? Clinical implications of psychedelic-associated subjective effects and the potential role of non-hallucinogenic alternatives The resurgence of interest in classical psychedelics brings both promise and challenges to psychiatric care. Increasing evidence supports the therapeu…

Here's a recent article we published on the clinical implications of the psychedelic experience, and emerging nonhallucinogenic analogues. Was fun working on this one!

www.sciencedirect.com/science/arti...

Congratulations Dr. Garland! Such a cool paper.

We've put together a data set of patients who presented to our emergency department after recreational psychedelics and ketamine use. Still working through it but excited to share the results

Really nice and important article. It's sometimes shocking how frequently my patients ask to be prescribed psilocybin mushrooms. It will be interesting to see how the next four years play out.

Opinion | What Kennedy Gets Right, And Wrong, About Antidepressants (Gift Article) Harm from these drugs is real. Let’s not cede the conversation to Kennedy.

An insightful and balanced perspective on antidepressants. Well worth the read! Thanks, @awaisaftab.bsky.social

Can Ketamine and Other Glutamate Receptor Modulators be Considered Entactogens? Subanesthetic-dose ketamine has recently been reported to improve hedonic pleasures associated with social interactions and altruism in individuals wi…

Interesting paper on ketamine’s empathogenic effects: sciencedirect.com/science/arti...
We explored similar effects with psilocybin: nature.com/articles/s44...
I wonder if ketamine-induced empathy depends on the quality of the acute subjective experience.